Allscripts Receives Infoway 2017 Edition Certification

TORONTO, March 16, 2020  CNW/ – Canada Health Infoway (Infoway) and Allscripts Healthcare Solutions (NASDAQ: MDRX) announced today that Allscripts Sunrise™ has achieved Infoway certification under the 2017 Edition Release 2 of pre-implementation certification requirements.

 “We congratulate Allscripts for achieving Infoway certification as an ambulatory electronic medical record (aEMR), approved for deployment at customer sites, with interoperability capabilities with laboratory and clinical documents,” said Mark Nenadovic, Senior Director, Programs & Alliances, Infoway. “This achievement ensures that the company’s solution conforms to the national and international standards for privacy, security and interoperability.”

Used by healthcare organizations across Canada and around the globe, Sunrise is an integrated electronic health record that connects all aspects of care, including acute, ambulatory, surgical, pharmacy, radiology and laboratory services. Built to enable efficient and safe care, Sunrise is a clinician-friendly, evidence-based single platform with integrated analytics that helps deliver true personalized care. Sunrise supports all core care venues across the enterprise by delivering a single patient record, and features patient-centric capabilities that increase access and convenience.

“Allscripts is proud to have achieved Infoway certification for our Sunrise platform and conformity to national and international standards for privacy, security and interoperability,” said John Lee-Bartlett, Country Director, Allscripts. “It underscores our continued commitment to Canada and ensures that we meet the highest standards for our healthcare solutions.”

Infoway certification provides assurance that digital health software complies with specified requirements and standards, which helps ensure the protection of personal health information. The 2017 Edition requirements build upon Infoway’s original certification requirements and are harmonized to increase alignment between Infoway, provincial requirements and international standards, and to reduce testing redundancies.

About Allscripts

Allscripts (NASDAQ: MDRX) is a leader in healthcare information technology solutions that advance clinical, financial and operational results. Our innovative solutions connect people, places and data across an Open, Connected Community of Health™. Connectivity empowers caregivers and consumers to make better decisions, delivering better care for healthier populations. To learn more, visit www.allscripts.comTwitterYouTube and It Takes A Community: The Allscripts Blog.

About Canada Health Infoway

Infoway helps to improve the health of Canadians by working with partners to accelerate the development, adoption and effective use of digital health across Canada. Through our investments, we help deliver better quality and access to care and more efficient delivery of health services for patients and clinicians. Infoway is an independent, not-for-profit organization funded by the federal government. Visit

Media Inquiries

Karen Schmidt
Director, Corporate/Internal Communications
Canada Health Infoway
Email Us
(Twitter button) Follow @Infoway

Concetta Rasiarmos
Public Relations

SOURCE Canada Health Infoway

For further information:

This information is being distributed to you by CNW Group Ltd. 88 Queens Quay West, Suite 3000 Toronto ON M5J 0B8
Please do not reply to this email. This is an outgoing message only. If you wish to stop receiving these types of messages from us, you can unsubscribe at any time.

Ces renseignements vous ont été distribués par le Groupe CNW Ltée. 88, Queens Quay Ouest, bureau 3000 Toronto, ON M5J 0B8
S’il vous plaît ne pas répondre à ce courriel. Il s’agit d’un message sortant seulement. Si vous ne souhaitez plus recevoir ce type de messages de notre part, vous pouvez vous désabonner à tout moment.

© 2020 CNW Group Ltd, all rights reserved
© 2020 Groupe CNW Ltée, tous droits réservés

share this article...
Share on FacebookShare on Google+Tweet about this on TwitterShare on LinkedIn

Leave a Reply

Your email address will not be published. Required fields are marked *

Not a robot? OK - prove it: *